For a girl who’s never had a period both her anatomy and the Axis Anatomy axis must be investigated. The diseases can be differentiated Breast Uterus Disease Diagnosis based on the table to the right. Remember ages 13 (2nd sex) and Imperforate Hymen Visual Inspection 15 (menarche). Anorexia/Weight Loss History Pregnant before period UPT / B-HCG Mullerian Agenesis Mullerian Agenesis Testosterone and The Mullerian ducts create the tubes, uterus, and the upper Androgen Insensitivity Karyotype third of the vagina. If they fail to form the girl will still be Cranipharyngioma ↓ FSH, ↓LH, MRI genetically female (X,X), so will have normal primary and Kallman’s Anosmia, FSH/LH normal secondary sex characteristics (the ovaries are working Turner’s ↑FSH, ↑LH, (X,O) great), but she’ll have no uterus. She can never have children Enzymatic deficiency N/A and will never bleed. To increase satisfaction with sex elevate the beyond our scope vagina to increase the length. This is considered a Breast Uterus disease. This is differentiated from testicular feminization based on the karyotype (X,X) and testosterone (X,O), Turner level (normal). (X,X) Ovaries E+P Breasts
Androgen Insensitivity / Testicular Feminization
A male genotype expresses mullerian inhibitory factor as well (X,Y) Mullerian Vulva/Vagina/Clitoris as testosterone. In this disease testosterone is made fine, but MIF Ducts there’s an insensitvity to testosterone by the body. Thus, despite Mullerian MIF = Ø Uterus, having testes, the primary and secondary sex characteristics are as if there was no testosterone - she appears totally female. Agenesis Tubes, Vagina MIF works perfectly and inhibits the mullerian ducts (see above). Uterus (X,Y) Testes Testosterone = Penis, Scrotum She’ll never have children or ever bleed. It’s imperative to elevate the vagina in this patient as we did in mullerian agenesis. Testicular Feminization There’s also the issue of the testes – perform an orchiectomy to Testes = No Ovaries prevent testicular cancer. Do this after age 20 (i.e. after puberty) to allow her to develop normally. This is considered a Breast Uterus disease. This is differentiated from Mullerian Agenesis by the karyotype (XY) and testosterone level (elevated). Normal Axis Kallman Turner Turner Syndrome A genetic abnormality (X,O) that causes the production of streak Hypothalamus Hypothalamus Hypothalamus ovaries. Patients are female with intact primary sex characteristics and mullerian structures ( uterus). But, in the GnRH ? ? GnRH E+P ? absence of estrogen she’ll never develop secondary sex Ant Pit Ant Pit Ant Pit characteristics. She’ll also have a broad, shield-shaped chest FSH LH ↓↓↓FSH LH ↑↑↑FSH LH with wide spaced nipples and a webbed neck. Lacking both Estrogen and Progesterone, treat by giving them what they don’t Ovary Ovary Ovary have (estrogen and progesterone) to induce puberty. Also E+P ? ? investigate for cardiac abnormalities with an Echo (coarctation of bicuspid aorta). In this disease, the FSH and LH will be high as Endometrium Endometrium Endometrium the normal pituitary tries to drive the production of estrogen and progesterone. Karyotype confirms. 1. Kallman: Absent hypothalamus can’t drive any endocrine function, so FSH and LH are low Craniopharyngioma and Kallman Syndrome 2. Craniopharyngioma: “No” anterior pit so FSH and LH are low. In both conditions the axis is broken. The anatomy is fine and 3. Turner: Absent ovaries can’t make E+P, so no signal to turn off intact (she’s female on the outside as well as inside), but the FSH and LH is present absence of endocrine effects leaves the girl without secondary
sex characteristics. Kallman syndrome is a defunct All girls should develop menarche by age 15 hypothalamus (so low FSH and LH) associated with anosmia and All girls should develop secondary sex char by age 13 primary amenorrhea. Craniopharyngioma and other anterior Girls who have not met age get reassurance pituitary tumors turn off the FSH and LH production. There is no Girls who have not met milestones by age get worked up anosmia, and an MRI will separate the diseases.
Herbert J. Wiser MD, Jay Sandlow MD, Tobias S. Köhler MD, MPh (Auth.), Sijo J. Parekattil, Ashok Agarwal (Eds.)-Male Infertility_ Contemporary Clinical Approaches, Andrology, ART & Antioxidants-Spring